Medical Oncology Grand Rounds

2020-2021 Academic Year

Date Speaker Title
Sep 18, 2020 Grant Challen The Epigenetic Regulation of Hematopoietic Stem Cells: From Clonal Hematopoiesis to Myeloid Neoplasia
Sep 25, 2020 Malachi Griffith Immunogenomics Approaches to Identify and Characterize Neoantigens
Oct 9, 2020 Andrew Young Clonal Hematopoiesis of Indeterminate and Determinate Potential
Oct 16, 2020 Vanessa Eulo Advancing Therapies in Sarcoma
Oct 30, 2020 Stephanie Perkins
Radiation Oncology
The Role of Proton Therapy in Adult Cancers
Brian Baumann
Radiation Oncology
The Promise of Proton Therapy as Part of Concurrent Chemo-Radiotherapy
Nov 6, 2020 Sid Devarakonda Implications of Cancer-"omics" Studies for Clinical Practice
Nov 13, 2020 Ryan Fields
Department of Surgery
The Clonal Evolution of Metastatic Colon Cancer: Insights and Implications for Patient Care
Dec 11, 2020 Ian Hu, MD, PhD
National Cancer Institute
Translational Research at NCI
Dec 18, 2020 Michael Slade Assessing Allogeneic Transplant Eligibility in Older Adults
Michael Iglesia Breast Cancer Subtypes at the Single-Cell Level: Results From the Human Tumor Atlas Network
Jan 8, 2021 Sanjeev Bhalla
Department of Radiology
Chest Imaging for the Oncologist
Jan 15, 2021 Fahrettin Covut Advances in Multiple Myeloma Treatment
David Russler-Germain Integrating Genomics Into Lymphoma Treatment Strategies
Jan 22, 2021 Michael Deininger, MD, PhD
Huntsman Cancer Institute, University of Utah
A Critical Role for SIRT5 in Acute Myeloid Leukemia Metabolism
Jan 29, 2021 Brian Miller, MD, PhD
Harvard Medical School, Dana Farber Cancer Institute
Defining Immune Mechanisms to Overcome Resistance to Immunotherapy
Feb 5, 2021 Amir Iravani
Department of Radiology
Molecular Imaging of Cancer and Immune Response to Immunotherapy
Feb 12, 2021 David S. Hong, MD
MD Anderson Cancer Center
Cracking Open the Undruggable RAS
Feb 19, 2021 Steven P. Treon, MD, PhD
Dana-Farber Cancer Institute
Treatment Advances in Waldenstrom's Macroglobulinemia
Feb 26, 2021 Whitney Hensing Targeting HER2 Mutations in Cancer
Raya Saba Overview and Advances in Treatment of Mantle Cell Lymphoma
Mar 5, 2021 Priyanka Verma, PhD
University of Pennsylvania
Chromatin Accessibility: A New Vulnerability in BRCA-Mutant Cancers
Mar 12, 2021 Dhruv Bansal Discovering an Immunologic Beachhead in the Prostate Tumor Microenvironment
Mar 19, 2021 Elizabeth M. Jaffee, MD
Johns Hopkins University
Pancreatic Cancer Is PRIMED to Become an Immunologic Disease
Mar 26, 2021 Barbara Burtness, MD
Yale School of Medicine
The Emerging Therapeutic Landscape in Head and Neck Cancer
Apr 2, 2021 Lindsay Peterson Precision Nutrition in Cancer Care
Apr 9, 2021 Zahra Kabiri, MD, PhD
Duke University
Interrogating the Role of Ras and Wnt Signaling Intensity in Colorectal Cancer
Apr 16, 2021 Robert Orlowski, MD, PhD
MD Anderson Cancer Center
Novel Antibody Drug Conjugates for Hematologic Malignancies
Apr 23, 2021 Miriam Jacobs The Role of Natural Killer Cells in Solid Tumor Immunotherapy
Apr 30, 2021 Ramon Jin The Role of SOX2 in Barrett's Esophagus and Esophageal Adenocarcinoma
May 7, 2021 Gradon Nielsen Impact of COVID on the Quality of Cancer Care Delivery
May 14, 2021 Jing Xi The Emerging Therapeutic Landscape in Breast Cancer With Brain Metastases
May 21, 2021 Christian Grommes, MD
Memorial Sloan Kettering Cancer Center
Primary CNS Lymphoma: Current Concepts and Changing Therapeutic Perspectives
May 28, 2021 Zachary Crees The GENESIS Trial - CXCR4 Inhibition With Motaxafortide + G-CSF for Hematopoietic Stem Cell Mobilization in Multiple Myeloma
Alice Zhou Multiple Myeloma and the Tumor Microenvironment: Focus on NK Cells and Therapeutic Exploitation
Jun 11, 2021 Carmen Bergom, MD, PhD
Radiation Oncology
Un-Break My Heart: Using Pre-Clinical and Clinical Data to Minimize Radiation-Induced Heart Dysfunction
Jun 18, 2021 Michael Kramer Machine Learning for the Oncologist: How the Machines Can Help You Help Patients
Jun 25, 2021 Kelsey S. Lau-Min, MD
University of Pennsylvania
Bridging the Evidence-To-Practice Gap in Cancer Care: The Precision Oncology Experience
Jul 2, 2021 Ryan Day Core-Binding Factor Leukemias: Mechanism and Treatment